Genovis
Genovis empowers the biopharma industry with innovative tools that support the development of novel biological drugs and diagnostics. Our flagship SmartEnzymes™ simplify analytical and preparative workflows for complex biopharmaceuticals, while the GlyCLICK® technology enables precise, site-specific IgG conjugation for ADC development without antibody engineering. By supporting customers in the generation and analysis of ADCs through cutting-edge tools and custom conjugation services, Genovis enables scientists to characterize and develop biological drugs, driving advancements in healthcare.